APC
VTAK

Aspire Private Capital’s Catheter Precision VTAK Stock Holding History

Aspire Private Capital’s Portfolio VTAK Stock Details VTAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1
Closed -$6 – 631
2024
Q3 		$6 Hold
1
– – ﹤0.01% 679
2024
Q2 		$70 Hold
1
– – ﹤0.01% 676
2024
Q1 		$58 Hold
1
– – ﹤0.01% 708
2023
Q4 		$48 Hold
1
– – ﹤0.01% 695
2023
Q3 		$53 Buy
+1
New +$116 ﹤0.01% 695
2023
Q2 		– Hold
0
– – – 673
2023
Q1 		– Hold
0
– – – 652
2022
Q4 		– Hold
0
– – – 638
2022
Q3 		– Hold
0
– – – 667
2022
Q2 		– Hold
0
– – – 647
2022
Q1 		– Hold
0
– – – 677
2021
Q4 		– Hold
0
– – – 610

Other funds holding VTAK

WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aspire Private Capital's VTAK Position: Q4 2024 in Review

Aspire Private Capital sold out of Catheter Precision (VTAK) in Q4 2024, closing a stake of 1 share — an estimated $6 sold.

Aspire Private Capital first reported a position in VTAK in Q3 2023 and held it in 5 quarters. The position peaked at $70 in Q2 2024. 8 funds tracked by Wall St. Rank hold VTAK as of Q4 2024.

  • Aspire Private Capital reported no remaining Catheter Precision position as of Q4 2024 after selling out during the quarter.
  • Aspire Private Capital sold 1 Catheter Precision share in Q4 2024, an estimated $6.
  • Aspire Private Capital first reported a position in Catheter Precision in Q3 2023 and held it in 5 quarters.
  • Aspire Private Capital's Catheter Precision position peaked at $70 in Q2 2024.
  • 8 funds tracked by Wall St. Rank held Catheter Precision as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.